MyFinsight
Home
Blog
About
CPS TECHNOLOGIES CORP DE (CPSH)
CPS TECHNOLOGIES CORP DE (CPSH)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$860,105
Free Cash flow
$876,808
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from sale of marketable...
Accrued expenses
Accounts payable
Others
Negative Cash Flow Breakdown
Purchase of marketable securitie...
Inventories
Purchases of property and equipm...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-27
2025-06-28
Net income (loss)
207,964
199,795
Depreciation and amortization
137,289
321,189
Share-based compensation
49,354
171,540
Realized gain on sale of marketable securities
-713
12,183
Deferred taxes
-113,601
-135,828
Accounts receivables-Trade Accounts Receivable
-202,623
744,495
Accounts receivables-Other Receivables
-39,377
238,961
Inventories
185,435
867,180
Prepaid expenses and other current assets
64,614
-217,350
Accounts payable
243,829
232,511
Accrued expenses
261,807
123,184
Deferred revenue
43,874
-142,045
Net cash provided by (used in) operating activities
1,050,382
-603,467
Purchases of property and equipment
173,574
265,918
Acquisition cost of patents and trademarks
4,542
21,363
Proceeds from sale of marketable securities
509,000
518,000
Purchase of marketable securities
521,161
525,772
Net cash used in investing activities
-190,277
-295,053
Payments on note payable
0
8,130
Net cash used in financing activities
0
-8,130
Net decrease in cash and cash equivalents
860,105
-906,650
Cash and cash equivalents at beginning of period
3,280,687
-
Cash and cash equivalents at end of period
3,234,142
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accrued expenses
$261,807
Accounts payable
$243,829
Net income (loss)
$207,964
Accounts
receivables-Trade Accounts...
-$202,623
Depreciation and
amortization
$137,289
Deferred taxes
-$113,601
Share-based compensation
$49,354
Deferred revenue
$43,874
Accounts
receivables-Other Receivables
-$39,377
Realized gain on sale of
marketable securities
-$713
Net cash provided by
(used in) operating...
$1,050,382
Canceled cashflow
$250,049
Net decrease in cash
and cash...
$860,105
Canceled cashflow
$190,277
Inventories
$185,435
Prepaid expenses and
other current assets
$64,614
Proceeds from sale of
marketable securities
$509,000
Net cash used in
investing activities
-$190,277
Canceled cashflow
$509,000
Purchase of marketable
securities
$521,161
Purchases of property and
equipment
$173,574
Acquisition cost of patents
and trademarks
$4,542
Buy us a coffee